Medical Subject Headings / 医学主题词表

Last uploaded: September 7, 2023
Preferred Name

Crizotinib

Synonyms

PF02341066

Definitions

A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.

ID

http://purl.bioontology.org/ontology/MESH/D000077547

altLabel

PF02341066

PF-2341066

PF-02341066

Xalkori

PF 2341066

PF 02341066

PF2341066

2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-

AQL

AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR

cui

C3204573

C2974289

C1957666

DC

1

definition

A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.

DX

20190101

HN

2019 (2010)

Inverse of AQ

http://purl.bioontology.org/ontology/MESH/Q000032

http://purl.bioontology.org/ontology/MESH/Q000138

http://purl.bioontology.org/ontology/MESH/Q000737

http://purl.bioontology.org/ontology/MESH/Q000493

http://purl.bioontology.org/ontology/MESH/Q000145

http://purl.bioontology.org/ontology/MESH/Q000506

http://purl.bioontology.org/ontology/MESH/Q000819

http://purl.bioontology.org/ontology/MESH/Q000037

http://purl.bioontology.org/ontology/MESH/Q000134

http://purl.bioontology.org/ontology/MESH/Q000592

http://purl.bioontology.org/ontology/MESH/Q000528

http://purl.bioontology.org/ontology/MESH/Q000008

http://purl.bioontology.org/ontology/MESH/Q000031

http://purl.bioontology.org/ontology/MESH/Q000276

http://purl.bioontology.org/ontology/MESH/Q000191

http://purl.bioontology.org/ontology/MESH/Q000633

http://purl.bioontology.org/ontology/MESH/Q000652

http://purl.bioontology.org/ontology/MESH/Q000009

http://purl.bioontology.org/ontology/MESH/Q000302

http://purl.bioontology.org/ontology/MESH/Q000494

http://purl.bioontology.org/ontology/MESH/Q000266

http://purl.bioontology.org/ontology/MESH/Q000600

http://purl.bioontology.org/ontology/MESH/Q000378

http://purl.bioontology.org/ontology/MESH/Q000097

http://purl.bioontology.org/ontology/MESH/Q000627

Inverse of RB

53AH36668S

0

isa

http://purl.bioontology.org/ontology/MESH/D000970

http://purl.bioontology.org/ontology/MESH/D047428

LT

TRD

Machine permutation

2010; CRIZOTINIB was indexed under PYRAZOLES and PYRIDINES 2010-2018

MDA

20180709

MMR

20180409

MN

D03.383.621.154

D03.383.725.050.263

notation

D000077547

PA

D047428

D000970

prefLabel

Crizotinib

TERMUI

T000940134

T699960

T832066

T783648

T777047

T783649

TH

NLM (2013)

NLM (2011)

US

USAN (19XX)

FDA SRS (2018)

NLM (2010)

NLM (2007)

INN (19XX)

tui

T109

T121

subClassOf

http://purl.bioontology.org/ontology/MESH/D000631

http://purl.bioontology.org/ontology/MESH/D010880

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C74061 National Cancer Institute Thesaurus / 美国国家癌症研究所词典 LOOM
http://purl.obolibrary.org/obo/CHEBI_64310 Chemical Entities of Biological Interest Ontology / 生物相关的化学实体本体 LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000183253 Ontology of Drug Adverse Events / 药物不良反应本体 LOOM
http://purl.bioontology.org/ontology/ATC/L01ED01 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 CUI
http://purl.bioontology.org/ontology/ATC/L01ED01 Anatomical Therapeutic Chemical Classification / 解剖学治疗学及化学分类系统 LOOM